← All candidates
14 insider buys in the last year — $22.44M in all.
15 filings on record.
BNTCBenitec Biopharma Inc.
NasdaqCM · Healthcare · $407.44M
$11.86
-1.58% · Jul 30
14 insider buys in the last year — $22.44M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 14 buys◆ 2 8-K
▸ hover a marker for the filing · drag to zoom · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$407.44M
Float
17.9M
52% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
Suvretta Capital Management, LLC
Bought $10.14M on Nov 7 — 751,111 sh @ $13.50, held indirect, 41% of their stake.
1 of 2 positions beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
10 more transactions on Pro →Context
Wall St
$24.33 avg target
+105.2% vs today · 6 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
The file stays open
15 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice